참고문헌
- Chin SH, Kahathuduwa CN and Binks M (2016) Physical activity and obesity: what we know and what we need to know. Obes Rev 17, 1226-1244 https://doi.org/10.1111/obr.12460
- Normandin E, Chmelo E, Lyles MF, Marsh AP and Nicklas BJ (2017) Effect of Resistance Training and Caloric Restriction on the Metabolic Syndrome. Med Sci Sports Exerc 49, 413-419
- Timmers S, Konings E, Bilet L et al (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14, 612-622 https://doi.org/10.1016/j.cmet.2011.10.002
- Haohao Z, Guijun Q, Juan Z, Wen K and Lulu C (2015) Resveratrol improves high-fat diet induced insulin resistance by rebalancing subsarcolemmal mitochondrial oxidation and antioxidantion. J Physiol Biochem 71, 121-131 https://doi.org/10.1007/s13105-015-0392-1
- Sparks LM, Xie H, Koza RA et al (2005) A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54, 1926-1933 https://doi.org/10.2337/diabetes.54.7.1926
- Civitarese AE, Ukropcova B, Carling S et al (2006) Role of adiponectin in human skeletal muscle biogenesis. Cell Metab 4, 75-87 https://doi.org/10.1016/j.cmet.2006.05.002
- Mootha VK, Lindfren CM, Eriksson KF et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267-273 https://doi.org/10.1038/ng1180
- Heilbronn LK, Gan SK, Turner N, Campbell LV and Chisholm DJ (2007) Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. J Clin Endocrinol Metab 92, 1467-1473 https://doi.org/10.1210/jc.2006-2210
- Bonnard C, Durand A, Peyrol S et al (2008) Mitochondrial dysfunction results from oxidative stress in skeletal muscle of diet-induced insulin resistant mice. J Clin Invest 118, 789-800
- Benton CR, Wright DC and Bonen A (2008) PGC-1alphamediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. Appl Physiol Nutr Metab 33, 843-862 https://doi.org/10.1139/H08-074
- Despres JP, Lemieux I, Bergeron J et al (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28, 1039-1049 https://doi.org/10.1161/ATVBAHA.107.159228
- Brouwers B, Hesselink MK, Schrauwen P and Schrauwen-Hinderling VB (2016) Effects of exercise training on intrahepatic lipid content in humans. Diabetologia 59, 2068-2079 https://doi.org/10.1007/s00125-016-4037-x
- Ahn J, Cho I, Kim S, Kwon D and Ha T (2008) Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 9, 1019-1028
- Savage DB, Petersen KF and Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87, 507-520 https://doi.org/10.1152/physrev.00024.2006
- Helge JW and Dela F (2003) Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity? Diabetes 52, 1881-1887 https://doi.org/10.2337/diabetes.52.8.1881
- Goodpaster BH, He J, Watkins S and Kelley DE (2001) Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86, 5755-5761 https://doi.org/10.1210/jcem.86.12.8075
- Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R and Dela F (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50, 790-796 https://doi.org/10.1007/s00125-007-0594-3
- Holloway GP, Thrush AB, Heigenhauser GJ et al (2007) Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women. Am J Physiol Endocrinol Metab 292, E1782-1789 https://doi.org/10.1152/ajpendo.00639.2006
- Wu Z, Puigserver P, Andersson U et al (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124 https://doi.org/10.1016/S0092-8674(00)80611-X
-
Ji LL and Kang C (2015) Role of PGC-
$1{\alpha}$ in sarcopenia: etiology and potential intervention-a mini-review. Gerontology 61, 139-148 - Atherton PJ, Babraj J, Smith K, Singh J, Rennie MJ and Wackerhage H (2005) Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J 19, 786-788 https://doi.org/10.1096/fj.04-2179fje
- Valero T (2014) Mitochondrial biogenesis: pharmacological approaches. Curr Pharm Des 20, 5507-5509 https://doi.org/10.2174/138161282035140911142118
- Lin J, Wu H, Tarr PT et al (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418, 797-801 https://doi.org/10.1038/nature00904
- Sun J, Huang T, Qi Z et al (2017) Early Mitochondrial Adaptations in Skeletal Muscle to Obesity and Obesity Resistance Differentially Regulated by High-Fat Diet. Exp Clin Endocrinol Diabetes 125, 538-546 https://doi.org/10.1055/s-0043-104634
- O'Neill BT, Kim J, Wende AR et al (2007) A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab 6, 294-306 https://doi.org/10.1016/j.cmet.2007.09.001